Is Cardiol Therapeutics Inc (CRDL) Stock at the Top of the Drug Manufacturers

A rating of 93 puts Cardiol Therapeutics Inc (CRDL) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Cardiol Therapeutics Inc's score of 93 means it scores higher than 93% of stocks in the industry. Cardiol Therapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 100 out of the 148 industries.

CRDL has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on CRDL!

See Full CRDL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 71 means the stock is more attractive than 71 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cardiol Therapeutics Inc Stock Today?

Cardiol Therapeutics Inc (CRDL) stock is trading at $1.88 as of 1:31 PM on Tuesday, Mar 26, a rise of $0.42, or 28.74% from the previous closing price of $1.46. The stock has traded between $1.50 and $1.95 so far today. Volume today is high. So far 754,940 shares have traded compared to average volume of 504,153 shares. Click Here to get the full Stock Report for Cardiol Therapeutics Inc stock.